Enteric hollow capsule
By employing a sealed connection between the outer shell and the internal thread structure and the chamber partition in the enteric-coated empty capsule, the problems of unstable capsule connection and drug accumulation are solved, achieving better sealing and drug absorption.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Utility models(China)
- Current Assignee / Owner
- Filing Date
- 2024-12-25
- Publication Date
- 2026-04-03
AI Technical Summary
The existing enteric-coated empty capsules have an unstable connection structure, which can easily create gaps under pressure, allowing stomach acid to enter and causing the internal medication to accumulate, thus affecting the drug's effectiveness.
The first and second capsule shells are connected by a sealed connection between the shell and the internal thread, combined with a convex ring and groove structure to enhance the connection strength, and a chamber partition and sugar coating film are set inside to prevent drug accumulation.
It improves the stability of capsule connection, avoids gap formation, enhances sealing performance and drug absorption efficiency, and improves drug efficacy and taste.
Smart Images
Figure CN224070839U_ABST
Abstract
Description
Technical Field
[0001] This utility model relates to the field of capsule technology, and in particular to an enteric-coated empty capsule. Background Technology
[0002] Enteric-coated empty capsules are made of capsule gelatin and suitable enteric materials. They are divided into ordinary enteric-coated capsules and colonic enteric-coated capsules. They are mainly used to contain solid drugs or other medications that are easily destroyed in the stomach. They solve the problem of difficult to swallow and poor taste for users, truly making good medicine no longer bitter. Empty capsules are becoming increasingly popular. First, the capsules are long and thin, making them easy to swallow. By filling the capsules with tasteless or slightly fragrant substances, the odor of the drug itself is masked, reducing the patient's resistance to taking the medication. Because the capsule walls are thick and not dissolved by gastric juice, they can effectively protect the drug from the erosion of gastric acid, thereby reducing the irritation of the gastric contents to the mucosa.
[0003] Enteric-coated empty capsules generally require water to be swallowed. During swallowing, the capsules are easily squeezed. However, the connection structure of existing enteric-coated empty capsules is not stable enough. After being squeezed, gaps are easily formed, allowing stomach acid to enter. Furthermore, the medication inside the capsules tends to accumulate, affecting the drug's effectiveness. Therefore, there is a need for an enteric-coated empty capsule. Utility Model Content
[0004] The purpose of this invention is to solve at least one of the technical problems existing in the prior art, and to provide an enteric-coated empty capsule that can solve the problems of unstable structure at the connection point of the enteric-coated empty capsule, which easily produces certain gaps after being squeezed, allowing gastric acid to enter, and the drugs inside the enteric-coated empty capsule easily accumulating together, affecting the efficacy of the drug.
[0005] To achieve the above objectives, this utility model provides the following technical solution: an enteric-coated empty capsule, comprising a first capsule shell A, a second capsule shell B disposed on one side of the first capsule shell A, a plurality of first anti-slip ridges A being formed on the outer surface of the first capsule shell A, a plurality of second anti-slip ridges B being formed on the outer surface of the second capsule shell B, the first anti-slip ridges A and the second anti-slip ridges B being identical in shape and number, a sealing connecting shell being fixedly connected inside the first capsule shell A, the outer surface of the sealing connecting shell being provided with external threads, a convex ring being fixedly sleeved on the outer surface of the sealing connecting shell, the inner wall of the second capsule shell B being provided with internal threads, the inner wall of the second capsule shell B being provided with grooves, the sealing connecting shell being threadedly connected to the inner thread of the second capsule shell B, the external threads being adapted to the internal threads, the convex ring being slidably connected inside the groove, the shape of the convex ring being adapted to the groove.
[0006] Preferably, the first capsule shell A has a receiving chamber A for containing the drug inside, and the second capsule shell B has a receiving chamber B for containing the drug inside, with the interior of receiving chamber B communicating with the interior of receiving chamber A.
[0007] Preferably, the inner wall of the first capsule shell A is fixedly connected with a plurality of upper chamber partitions, and the inner wall of the first capsule shell A is fixedly connected with a plurality of lower chamber partitions.
[0008] Preferably, the number of upper chamber partitions and lower chamber partitions are the same and they are staggered, and both upper chamber partitions and lower chamber partitions are located inside the receiving chamber A.
[0009] Preferably, a partition is fixedly connected inside the second capsule shell B, and the partition is located inside the receiving chamber B.
[0010] Preferably, the inner wall surface of the first capsule shell A is provided with a first sugar coating film A.
[0011] Preferably, the inner wall surface of the second capsule shell B is provided with a second sugar coating film B.
[0012] Compared with the prior art, the beneficial effects of this utility model are:
[0013] 1. This enteric-coated empty capsule strengthens the connection between the first capsule shell A and the second capsule shell B by sealing the outer shell threadedly inside the second capsule shell B. The connection between the first capsule shell A and the second capsule shell B is further tightened by inserting a protruding ring into a groove, enhancing the sealing performance and preventing loosening between them. The upper and lower chamber partitions and the first sugar coating film A inside the first and second capsule shells separate the internal chambers, preventing drug accumulation and enhancing drug absorption efficiency. Attached Figure Description
[0014] The present invention will be further described below with reference to the accompanying drawings and embodiments:
[0015] Figure 1 This is a schematic diagram of the main body of this utility model;
[0016] Figure 2 This is a schematic diagram of the internal structure of this utility model;
[0017] Figure 3 This is a schematic diagram of the first capsule shell A of this utility model;
[0018] Figure 4 This is a schematic diagram of the receiving chamber A of this utility model;
[0019] Figure 5 This is a schematic diagram of the second capsule shell B of this utility model;
[0020] Figure 6 For the present utility model Figure 5 Schematic diagram at point A in the middle.
[0021] Reference numerals: 1. First capsule shell A; 2. Second capsule shell B; 3. First anti-slip ridge A; 4. Second anti-slip ridge B; 5. Sealing connection shell; 6. External thread; 7. Raised ring; 8. Internal thread; 9. Groove; 10. Separator; 11. Receiving chamber B; 12. Receiving chamber A; 13. Upper chamber separator; 14. Lower chamber separator; 15. First sugar coating film A; 16. Second sugar coating film B. Detailed Implementation
[0022] This section will describe in detail the specific embodiments of the present utility model. The preferred embodiments of the present utility model are shown in the accompanying drawings. The purpose of the drawings is to supplement the textual description with graphics, so that people can intuitively and vividly understand each technical feature and the overall technical solution of the present utility model, but they should not be construed as limiting the scope of protection of the present utility model.
[0023] In the description of this utility model, it should be understood that the directional descriptions, such as up, down, front, back, left, right, etc., indicate the directional or positional relationship based on the directional or positional relationship shown in the accompanying drawings. They are only for the convenience of describing this utility model and simplifying the description, and do not indicate or imply that the device or element referred to must have a specific orientation, or be constructed and operated in a specific orientation. Therefore, they should not be construed as limitations on this utility model.
[0024] In the description of this utility model, terms such as greater than, less than, and exceeding are understood to exclude the stated number, while terms such as above, below, and within are understood to include the stated number. The use of terms like "first" and "second" is merely for distinguishing technical features and should not be construed as indicating or implying relative importance, or implicitly indicating the quantity or sequence of the indicated technical features.
[0025] In the description of this utility model, unless otherwise explicitly defined, terms such as "setting," "installation," and "connection" should be interpreted broadly, and those skilled in the art can reasonably determine the specific meaning of the above terms in this utility model in conjunction with the specific content of the technical solution.
[0026] Please see Figure 1-6This utility model provides a technical solution: an enteric-coated empty capsule, including a first capsule shell A1, a second capsule shell B2 disposed on one side of the first capsule shell A1, a plurality of first anti-slip ridges A3 formed on the outer surface of the first capsule shell A1, a plurality of second anti-slip ridges B4 formed on the outer surface of the second capsule shell B2, the first anti-slip ridges A3 and the second anti-slip ridges B4 having the same shape and number, a sealing connecting shell 5 fixedly connected inside the first capsule shell A1, an external thread 6 formed on the outer surface of the sealing connecting shell 5, a convex ring 7 fixedly sleeved on the outer surface of the sealing connecting shell 5, an internal thread 8 formed on the inner wall of the second capsule shell B2, a groove 9 formed on the inner wall of the second capsule shell B2, the sealing connecting shell 5 and the second capsule shell B2 being internally threadedly connected, the external thread 6 being adapted to the internal thread 8, the convex ring 7 being slidably connected inside the groove 9, the convex ring 7 being adapted to the shape of the groove 9.
[0027] Furthermore, the first capsule shell A1 has an internal cavity A12 for containing the drug, and the second capsule shell B2 has an internal cavity B11 for containing the drug. The internal cavity B11 is connected to the internal cavity A12. The inner wall of the first capsule shell A1 is fixedly connected to a plurality of upper cavity partitions 13 and a plurality of lower cavity partitions 14. The number of upper cavity partitions 13 and lower cavity partitions 14 are the same and they are staggered. Both upper cavity partitions 13 and lower cavity partitions 14 are located inside the internal cavity A12. The internal cavity of the second capsule shell B2 is fixedly connected to a partition 10, which is located inside the internal cavity B11. The inner wall surface of the first capsule shell A1 is provided with a first sugar coating film A15, and the inner wall surface of the second capsule shell B2 is provided with a second sugar coating film B16.
[0028] Furthermore, the sealing connection shell 5 provided on the first capsule shell A1 is threaded onto the inner wall of the second capsule shell B2 by the adaptation of the external thread 6 and the internal thread 8. The convex ring 7 on the sealing connection shell 5 slides into the interior of the second capsule shell B2 and then into the groove 9 provided on the second capsule shell B2. The convex ring 7 is frustoconical in shape and matches the shape of the groove 9. It can be inserted into the interior of the groove 9 and limit the first capsule shell A1 and the second capsule shell B2. Since the sealing connection shell 5 is threaded into the interior of the second capsule shell B2, it has a tighter connection strength. By inserting the convex ring 7 into the interior of the groove 9, loosening can be avoided, and the sealing performance of the capsule can be strengthened. The upper chamber partition 13, the lower chamber partition 14 and the first sugar coating film A15 provided inside the first capsule shell A1 and the second capsule shell B2 can separate the internal chambers of the first capsule shell A1 and the second capsule shell B2, preventing the drugs from accumulating together.
[0029] Furthermore, the connection strength between the first capsule shell A1 and the second capsule shell B2 is strengthened by threading the sealing connection shell 5 inside the second capsule shell B2. The connection between the first capsule shell A1 and the second capsule shell B2 is made tighter by inserting the convex ring 7 into the groove 9, enhancing the sealing performance and preventing loosening between the first capsule shell A1 and the second capsule shell B2. The upper chamber partition 13, the lower chamber partition 14, and the first sugar coating film A15 provided inside the first capsule shell A1 and the second capsule shell B2 can further connect the first capsule shell A1 and the second capsule shell B2. The internal chambers of the outer shell B2 are separated to prevent the drugs from piling up and to enhance drug absorption efficiency. The first sugar coating film A15 and the second sugar coating film B16 can improve the taste of the capsule. The first anti-slip ridge A3 and the second anti-slip ridge B4 on the first capsule shell A1 and the second capsule shell B2 make the capsule less likely to fall off when handled, increasing its practicality. The above structural design solves the problems of insufficient structural stability at the connection of enteric-coated empty capsules, which can easily create gaps after being squeezed, allowing gastric acid to enter, and the drugs inside enteric-coated empty capsules tend to pile up, affecting the efficacy of the drug.
[0030] Structural Description: First Capsule Shell A1: Part of the capsule shell, used to encapsulate the drug;
[0031] Second capsule shell B2: A part of the capsule shell used to encapsulate the drug;
[0032] First anti-slip ridge A3: The first anti-slip ridge A3 is exactly the same as the second anti-slip ridge B4. It is used to increase friction and prevent the capsule from falling off when it is placed and picked up due to the smooth surface of the capsule.
[0033] Sealing connection housing 5: fixed inside the first capsule housing A1, used to fix the first capsule housing A1 and the second capsule housing B2;
[0034] External thread 6: Provided on the outer surface of the sealing connection housing 5, used to enhance the installation stability of the sealing connection housing 5 and the second capsule housing B2;
[0035] convex ring 7: set on the outer surface of the sealing connection housing 5, used to cooperate with the groove 9 to make the installation of the sealing connection housing 5 more stable and improve the sealing performance;
[0036] Internal thread 8: Located inside the second capsule shell B2, and adapted to external thread 6;
[0037] Groove 9: Formed inside the second capsule shell B2, it is adapted to the convex ring 7 and limits the position of the convex ring 7;
[0038] Separator 10: Fixed inside the second capsule shell B2, used to separate the receiving chamber B11 and increase the uniformity of drug distribution;
[0039] Receiving chamber B11: Located inside the second capsule shell B2, for holding the drug;
[0040] Receiving chamber A12: Located inside the first capsule shell A1, it contains the drug;
[0041] Upper chamber partition 13: There are multiple upper chamber partitions 13, which are fixed to the inner wall of the first capsule shell A1, thus separating the receiving chamber A12 and increasing the uniformity of drug distribution.
[0042] Lower chamber partition 14: There are multiple lower chamber partitions 14, which are fixed to the inner wall of the first capsule shell A1, and separate the receiving chamber A12 to increase the uniformity of drug distribution.
[0043] First sugar coating film A15: Adhesive to the inner wall of the first capsule shell A1 to enhance the taste of the capsule;
[0044] Second sugar coating film B16: Adhesive to the inner wall of the second capsule shell B2, enhancing the capsule's taste.
[0045] The embodiments of the present utility model have been described in detail above with reference to the accompanying drawings. However, the present utility model is not limited to the above embodiments. Within the scope of knowledge possessed by those skilled in the art, various changes can be made without departing from the spirit of the present utility model.
Claims
1. An enteric, hollow capsule comprising a first capsule shell A (1), characterized in that: The side of the first capsule shell A (1) is provided with a second capsule shell B (2), a plurality of first anti-skid edges A (3) are arranged on the outer surface of the first capsule shell A (1), a plurality of second anti-skid edges B (4) are arranged on the outer surface of the second capsule shell B (2), and the shape and number of the first anti-skid edges A (3) and the second anti-skid edges B (4) are completely same. The inner wall of the first capsule shell A (1) is fixedly connected with a sealing connecting shell (5), the outer surface of the sealing connecting shell (5) is provided with external threads (6), and the outer surface of the sealing connecting shell (5) is fixedly sleeved with a convex ring (7). The inner wall of the second capsule shell B (2) is provided with internal threads (8), the inner wall of the second capsule shell B (2) is provided with a groove (9), the sealing connecting shell (5) is threadedly connected with the second capsule shell B (2), the external threads (6) are matched with the internal threads (8), the convex ring (7) is slidably connected in the groove (9), and the convex ring (7) is matched with the groove (9).
2. An enteric hollow capsule according to claim 1, characterized in that: The inner wall of the first capsule shell A (1) is provided with an accommodating cavity A (12) for accommodating the medicine, the inner wall of the second capsule shell B (2) is provided with an accommodating cavity B (11) for accommodating the medicine, and the inner wall of the accommodating cavity B (11) is in communication with the inner wall of the accommodating cavity A (12).
3. The enteric hollow capsule according to claim 1, wherein: The inner wall of the first capsule shell A (1) is fixedly connected with a plurality of upper cavity dividing portions (13), and the inner wall of the first capsule shell A (1) is fixedly connected with a plurality of lower cavity dividing portions (14).
4. An enteric, hollow capsule according to claim 3, characterized in that: The number of the upper cavity dividing portions (13) and the lower cavity dividing portions (14) is same and staggered, and the upper cavity dividing portions (13) and the lower cavity dividing portions (14) are located in the accommodating cavity A (12).
5. The enteric, hollow capsule according to claim 1, characterized in that: The inner wall of the second capsule shell B (2) is fixedly connected with a dividing piece (10), and the dividing piece (10) is located in the accommodating cavity B (11).
6. The enteric, hollow capsule of claim 1, wherein: The inner wall surface of the first capsule shell A (1) is provided with a first sugar-coated film A (15).
7. The enteric, hollow capsule of claim 1, wherein: The inner wall surface of the second capsule shell B (2) is provided with a second sugar-coated film B (16).